Plants as a source of anticancer agents

An attempt has been made to review some medicinal plants used for the prevention and treatment of cancer. Plant derived compounds have played an important role in the development of several clinically useful anticancer agents. Several anticancer agents including taxol, vinblastine, vincristine and topotecan are in clinical use all over the world. A number of promising agents such as combrestatin, betulinic acid and silvesterol are in clinical or preclinical development.

[1]  K. Lee,et al.  Homoharringtonine and related compounds , 2005 .

[2]  S. Arbuck,et al.  Camptothecin and Its Analogs , 1996 .

[3]  D. Chaplin,et al.  The discovery and development of the combretastatins , 2005 .

[4]  J. Fahy,et al.  7 The Vinca Alkaloids , 2005 .

[5]  M. Boyd,et al.  Ethnobotany and drug discovery: the experience of the US National Cancer Institute. , 2007, Ciba Foundation symposium.

[6]  C. Bocca,et al.  Biological properties of jatrophane polyesters, new microtubule-interacting agents , 2002, Cancer Chemotherapy and Pharmacology.

[7]  J L Hartwell,et al.  PLANTS USED AGAINST CANCER , 1989 .

[8]  R. Cichewicz,et al.  Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection , 2004, Medicinal research reviews.

[9]  D. Kingston.  Taxol and Its Analogs , 2005 .

[10]  J L Hartwell,et al.  Plants used against cancer. A survey. , 1970, Lloydia.

[11]  David J Newman,et al.  A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy. , 2004, Journal of natural products.

[12]  L. Kapoor.  CRC handbook of ayurvedic medicinal plants , 1989 .

[13]  M. Konopleva,et al.  Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-γ expression , 2004 .

[14]  D. Newman,et al.  Plants as a source of anti-cancer agents. , 2005, Journal of ethnopharmacology.

[15]  H. Sham,et al.  Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer , 2002 .

[16]  A. Kinghorn,et al.  The discovery of drugs from higher plants. , 1994, Biotechnology.

[17]  D. Kingston,et al.  Anticancer Agents from Natural Products , 2005 .

[18]  L. O’Driscoll.  Current Cancer Drug Targets , 2009 .

[19]  Dn Baron,et al.  Molecular Aspects of Medicine , 1981 .

[20]  G. Samuelsson.  Drugs of natural origin : a textbook of pharmacognosy , 1999 .

[21]  Chris Williams.  Oncology , 1990, The Lancet.

[22]  J. Douros,et al.  Anticancer agents based on natural product models , 1980 .

[23]  David J Newman,et al.  Natural products and derivatives as leads to cell cycle pathway targets in cancer chemotherapy. , 2002, Current cancer drug targets.

[24]  M. Sporn,et al.  Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action. , 2005, Bioorganic & medicinal chemistry letters.

[25]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[26]  Laurent Meijer,et al.  Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. , 2003, Accounts of chemical research.

[27]  H. Lilja,et al.  Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. , 2003, Journal of the National Cancer Institute.

[28]  K. Lee,et al.  Podophyllotoxins and analogs , 2005 .

[29]  Jussi Taipale,et al.  Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. , 2002, Genes & development.